Lataa...
EGFR-mutated lung cancer: a paradigm of molecular oncology
The development of EGFR tyrosine kinase inhibitors for clinical use in non-small cell lung cancer and the subsequent discovery of activating EGFR mutations have led to an explosion of knowledge in the fields of EGFR biology, targeted therapeutics and lung cancer research. EGFR-mutated adenocarcinoma...
Tallennettuna:
| Päätekijät: | , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Impact Journals LLC
2010
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3001953/ https://ncbi.nlm.nih.gov/pubmed/21165163 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|